Alnylam Pharmaceuticals, Inc.

DUL.F·Frankfurt·Healthcare
Compare
145.15+0.10 (+0.07%)today
As of Nov 5, 8:10 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close145.05
Open145.15
Day range—
52-week range140.25408.00
Off day high0.00%
Off 52-week high−64.42%
Volume32.00
Avg. volume (3M)26.00
Market cap19.44B
EPS (TTM)17.04
Forward P/E-38.60
P/E ratio (TTM)8.52
Dividend yield—
Beta (5Y)0.27
Shares outstanding133.94M
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin52.85%

Against its peers

Compare in full ›
DUL.F ARWR IONS BBIO 4591.T ROIV
Market cap 19.44B 8.71B 6.67B 15.17B 3.39B 27.61B
P/E (TTM) 8.5 — — — — —
Forward P/E -38.6 -12.4 -35.0 -225.0 -1.1 -27.5
Price/book 6.1 18.7 15.1 -5.9 1.2 6.5
Dividend yield — — — — — —
1-year change −62.59% +55.68% −45.82% +24.17% −29.21% +85.85%
Today +0.07% +3.56% −0.67% +5.21% −4.76% +6.08%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Latest news

All DUL.F news ›

From the 4Search news index, newest first.

In the news

18mentions in 30 days
18with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 18 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance